...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Two big thank you’s

I'd like to thank the parties that created the Ora of death for ZHCLF shares potentially being halted in trading and the other person that traded 500 shares of the company yesterday at .075 to allow me to transfer a good portion of those newly acquired shares into my TSFA at a ridiculously cheap price.

tada 

Share
New Message
Please login to post a reply